Fresh analysis indicates that patients who come off new GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass far faster than those who halt conventional lifestyle programs.
Findings released in a major health publication demonstrates that while obese people often shed about a fifth of their body weight while using the jabs, the mass is regained at an average rate of nearly a kilo each month once they quit.
"Users purchasing such treatments need to be cognizant of the risk of quick weight regain when the treatment is stopped," stated expert Dr. Susan Jebb.
Such speed of regain implies a return to starting mass in about one and a half years.
Comparing Treatments
The research, which looked at 37 of trials involving thousands of patients, compared the results of these new drugs with other pills.
Scientists note that individuals who lose weight through lifestyle changes alone typically experience a less rapid weight regain—around 0.1 kg a month—once they finish.
Explaining the Fast Regain
Experts believe the way of the injections is key to understanding the amplified rebound.
These medications mimic a body's own chemical called GLP-1, which helps regulate feelings of fullness.
"Long-term administration of the hormone concentrations several times higher than the body's typical production might result in the body to produce less of its endogenous hormone, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Stopping of this hormone supplement means hunger is no longer kept in check, making overeating far more likely."
A Chronic Condition?
The NHS recommend the jabs for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
Many experts contend that, considering the high risk of relapse, the treatment is often ongoing.
This view is reinforced by drug manufacturers, who say that the results "highlight the chronic nature of obesity," comparing it to managing conditions like hypertension.
User Testimonies
Individuals who have stopped the medication explain a sudden return of appetite.
"It felt as if a switch that goes on and you become starving," said an individual.
This difficulty is worsened if individuals have not established lasting lifestyle or habit changes during therapy.
Widespread Adoption
Survey data indicate that millions of adults in the UK have tried these injections in the last 12 months, with interest remaining high.
- Use is higher among females compared to males.
- The middle-aged age group shows the greatest usage rates.
- A large proportion access the medications through private healthcare rather than public health services.
Ultimately, clinicians emphasize that while the jabs are effective tools for weight loss, they are not a magic cure and lasting health benefits relies on integrated lifestyle changes.
